GS Paper: GS2-13.Issues relating to development and management of Social Sector/Services relating to Health, Education, Human Resources.

Mentor’s Comment

India committed in 2017 to restrict the advertising of ultra-processed foods (UPFs) and foods high in fat, sugar and sodium (HFSS) foods under the National Multisectoral Action Plan, but that commitment remains unimplemented. In February 2026, the Supreme Court of India weighed in on the issue through a PIL on front-of-pack warning labels, and the Economic Survey 2025-26 called for stronger regulation of UPF advertising, bringing the policy gap into sharp focus.

What has made UPF and HFSS advertising a public health concern?

1. Rising exposure: Children and adolescents encounter UPF advertisements across television, social media, sports broadcasts and influencers.
2. Misleading health claims: Advertisements highlight selective attributes such as “baked”, “multigrain” or “12-grain” and conceal high sugar, salt and fat content.
3. Targeted marketing: Celebrity endorsements and child actors increase product appeal among vulnerable consumers.
4. Demand creation: Advertising does not merely reflect demand. It actively shapes consumer preferences and consumption patterns.
5. Scale of advertising expenditure: In 2024, three major transnational corporations spent USD 13.2 billion on UPF advertising globally. In India alone, more than two lakh junk food advertisements appeared in a single month, backed by an advertising expenditure of approximately ₹170 crore.

Why are UPFs increasingly linked to adverse health outcomes?

1. Industrial formulation: UPFs contain additives, flavour enhancers, emulsifiers and refined ingredients designed for high palatability.
2. Overconsumption effect: Their design encourages repeated consumption and reduces satiety.
3. Diet displacement: UPFs replace traditional and minimally processed foods.
4. Disease burden: Scientific evidence links high UPF consumption to obesity, hypertension, diabetes and cardiovascular diseases.
5. Rising NCD challenge: Growing UPF consumption coincides with increasing obesity rates globally and in India.

Why are existing regulatory safeguards proving inadequate?

1. Policy implementation gap: The National Multisectoral Action Plan (2017-2022) envisaged restrictions on HFSS advertising, but implementation remains incomplete.
2. Weak disclosure norms: Advertisements can omit critical nutritional information and still remain legally compliant.
3. Limited consumer protection: Existing rules focus more on product safety than marketing practices.
4. Judicial concern: The Supreme Court has highlighted the need for stronger consumer information measures such as front-of-pack labelling.
5. Reliance on self-regulation: Industry-led safeguards have not substantially reduced child-targeted advertising.

What Is the Constitutional and Legal Basis for Restricting UPF and HFSS Advertising?

1. State duty to protect vulnerable groups: Children are especially vulnerable to food marketing, requiring state intervention to safeguard public health.
2. Existing policy commitment: The NMAP (2017-22) envisaged restrictions on HFSS food advertising, but implementation remains pending.
3. Advertising law as the key instrument: The proposed solution is amendment of advertising laws, a measure already contemplated by the government.
4. Supporting legal measures: The Supreme Court (2026) endorsed front-of-pack labelling, while MPs have advocated warning labels and taxation of UPFs.
5. Right to health framework: Regulation of unhealthy food advertising flows from the constitutional right to health and is supported by the Economic Survey 2025-26.

Does nutrition education alone solve the problem?

1. Information asymmetry: Consumers receive nutrition advice but are simultaneously exposed to aggressive food marketing.
2. Behavioural influence: Marketing exploits emotional triggers that often outweigh rational dietary choices.
3. Children’s vulnerability: Children lack the capacity to critically assess persuasive advertising.
4. Environmental constraint: Food choices are shaped by the surrounding commercial environment, not only by awareness levels.
5. Public health limitation: Education programmes cannot fully offset continuous exposure to unhealthy food promotion.

What do international experiences demonstrate about food advertising regulation?

1. City of San Francisco lawsuit against UPF manufacturers: In 2024, San Francisco filed a lawsuit against 10 major UPF manufacturers alleging child-targeted marketing, highly compelling product formulations, and inadequate health risk disclosure. The suit sought prevention of deceptive marketing and corrective measures for past false advertising.
2. Chile: Strong statutory restrictions on unhealthy food advertising reduced reliance on voluntary industry commitments.
3. Mexico: Regulatory interventions demonstrated greater effectiveness than self-regulation mechanisms.
4. Global evidence: International experience shows enforceable legal measures outperform voluntary compliance frameworks.
5. Lancet Series evidence (November 2025): Three papers published in The Lancet in November 2025 presented scientific evidence linking UPF consumption to poorer diet quality, displacement of real foods, hypertension, cardiovascular disease, type 2 diabetes, obesity, and other non-communicable diseases. The series argued that policymaking should not wait for further evidence.

Why is this ultimately a state responsibility rather than a market choice?

1. Right to Health: The state has a constitutional duty to protect public health when harms are foreseeable.
2. Child protection principle: Children constitute a vulnerable group requiring enhanced regulatory safeguards.
3. Market failure: Consumers often lack complete information about nutritional risks.
4. Externalities: Rising obesity and NCDs impose social and healthcare costs beyond individual consumers.
5. Public interest regulation: Restrictions on harmful advertising are comparable to other public health interventions.

What policy changes are required?

1. Advertising restrictions: Prohibit or significantly restrict child-targeted advertising of UPFs and HFSS foods.
2. Front-of-pack labelling: Introduce clear warning labels to improve informed choice.
3. Digital platform regulation: Extend restrictions to social media, influencers and online advertising.
4. Stronger enforcement: Replace voluntary compliance with statutory obligations and penalties.
5. Healthy food promotion: Incentivise marketing of minimally processed and nutritious foods.

Conclusion

The central issue is not consumer ignorance but the commercial environment that shapes food choices. Nutrition education cannot succeed when aggressive marketing continuously promotes unhealthy foods. India’s public health response must move beyond awareness campaigns and regulate the advertising ecosystem that drives UPF consumption, especially among children.

Mentor’s Comment

NFHS-6 indicates that India has achieved substantial progress in public health delivery. The central challenge has shifted from expanding access to services toward improving caregiving, feeding behaviour, maternal support, and diet quality.

What change does NFHS-6 reveal in India’s nutrition landscape?

1. Decline in Stunting: Stunting among children under five declined from 35.5% to 29.3%.
2. Better Maternal Care: Around 95% of mothers received antenatal care.
3. Rise in Institutional Deliveries: Institutional births reached about 90%.
4. Higher Immunisation Coverage: About 87% of children aged 12–23 months are fully vaccinated.
5. Improved Public Health Access: Better housing, sanitation, education, and health services have strengthened child health outcomes.

Why has nutrition progress lagged behind improvements in health indicators?

1. Poor Breastfeeding Practices: Only about half of newborns are breastfed within the first hour of birth.
2. Delayed Complementary Feeding: Many children do not receive timely solid and semi-solid foods after six months. In many households, complementary feeding begins only after annaprasana. Delays during this period contribute to growth faltering.
3. Inadequate Diet Diversity: Only around 15% of children aged 6-23 months receive an adequate diet.
4. Persistent Wasting: Severe wasting indicators show limited improvement.
5. Weak Feeding Awareness: Families often lack information regarding age-appropriate nutrition.

Why is maternal time poverty emerging as a major nutrition challenge?

1. Double Burden of Work: Women perform paid and unpaid work simultaneously.
2. Informal Labour Participation: Large numbers of women work in agriculture and informal sectors.
3. Childcare Deficit: Lack of crèches forces many mothers to leave infants with relatives or older siblings.
4. Crèches as Nutrition Infrastructure: Community childcare centres improve feeding continuity, support breastfeeding and reduce women’s unpaid care burden.
5. Disrupted Feeding Practices: Work responsibilities reduce breastfeeding and complementary feeding frequency.
6. Limited Childcare Infrastructure: Rural areas lack adequate crèches and support systems.

Why does greater food expenditure not guarantee better nutrition?

1. Consumer Expenditure Shift: Recent Consumer Expenditure Survey findings show declining spending on cereals and rising expenditure on dairy, processed foods and beverages.
2. Nutrition-Diversity Gap: Dietary diversity does not necessarily ensure nutritional adequacy.
3. Affordability Constraints: Pulses, fruits, vegetables, nuts, and animal-source foods remain expensive.
4. Convenience Advantage: Processed foods are easily available and ready to consume.
5. Departure from NIN Guidelines: Many household diets diverge from recommended nutritional patterns.

Why must India’s nutrition strategy move beyond treatment to prevention?

1. Critical First 1,000 Days: Nutrition from pregnancy to age two determines lifelong outcomes.
2. Early Growth Faltering: Stunting and growth failure begin well before severe malnutrition becomes visible. Growth faltering often begins before severe malnutrition becomes visible and peaks during the second year of life.
3. Need for Early Detection: Regular anthropometric monitoring can identify risks sooner.
4. Preventive Counselling: Timely guidance to mothers can prevent nutrition deficits.
5. Focus on At-Risk Children: Current interventions remain heavily oriented toward severe cases.
6. 0-2 Years Data Gap: Lack of disaggregated data for children aged 0-2 years limits targeted interventions during the most critical growth period.
7. POSHAN Focus Gap: Current identification systems focus on severely malnourished children rather than children beginning to show growth decline

What implementation gaps weaken frontline nutrition delivery?

1. Data Quality Challenges: Large volumes of nutrition data remain underutilised.
2. Limited Analytical Capacity: Local-level analysis and feedback mechanisms remain weak.
3. Training Deficits: AWWs, ASHAs, and ANMs need stronger nutrition counselling skills.
4. Human Resource Gaps: District-level nutritionists and data analysts are inadequate.
5. Limited Digital Support: Technology tools remain underused for counselling and monitoring.

Why is child malnutrition not merely a health-sector problem?

1. Water and Sanitation Linkages: Safe drinking water and sanitation directly influence nutrition outcomes.
2. Local Governance Role: Gram Sabhas and Panchayats can prioritise nutrition interventions.
3. Need for Convergence: Health, ICDS, education, and local governments must coordinate.
4. Gender Dimension: Women’s economic participation requires childcare support systems.
5. Role of Men in Caregiving: Shared domestic responsibilities improve child feeding practices.

What is the central tension in India’s nutrition transition?

1. Access vs Outcomes: Health-care access has improved substantially, but nutrition outcomes lag behind.
2. Health Care vs Nutrition Outcomes: India has largely solved access-related deficits in maternal and child health, but feeding practices, caregiving constraints and diet quality now drive malnutrition.
3. Treatment vs Prevention: Policy focus remains stronger on rehabilitation than early prevention.
4. Food Availability vs Nutrition Quality: More food spending does not ensure better diets.
5. Women’s Work vs Childcare Needs: Economic participation often competes with caregiving responsibilities.
6. Data Generation vs Data Utilisation: India collects extensive nutrition data but uses it inadequately for corrective action.

Conclusion

NFHS-6 shows that India has largely succeeded in expanding health-care access and public service delivery. The next phase of nutrition improvement depends on correcting feeding practices, reducing maternal time poverty, improving diet quality, strengthening frontline counselling, and using nutrition data for preventive action. Better health care alone cannot overcome India’s nutrition challenge.

Mentor’s Comment

The release of NFHS-6, the National Health Accounts Estimates (2022-23), and the NSSO 80th Round on Health has renewed attention on India’s health indicators. India’s primary challenge is no longer generating health data but ensuring that survey findings translate into accountability, budgetary decisions, and programme correction.

What challenges do India’s health surveys reveal?

1. Rising Non-Communicable Diseases (NCDs): NFHS-6 reports increasing obesity, diabetes and hypertension across social and economic groups.
2. Persistent Out-of-Pocket Expenditure: National Health Accounts continue to show significant household spending on healthcare.
3. Nutrition Challenges: Survey findings indicate that several nutrition-related concerns remain inadequately addressed.
4. Expansion of Disease Burden: Health problems once concentrated among urban and affluent groups have spread across wider sections of society.
5. Recurring Evidence: Successive surveys continue to identify many of the same structural weaknesses in India’s health system.
6. Out-of-pocket expenditure: It declined as a share of Total Health Expenditure from 62.6% (2014-15) to 39.4% (2022-23).
7. Obesity and Lifestyle Diseases: Female obesity increased from 24% to 28%, while male obesity increased from 23% to 25% between NFHS-5 and NFHS-6. Diabetes rose from 14% to 17% among women and 16% to 18% among men.
8. High Medicine Costs: NSSO health data show medicines remain the largest component of household health expenditure, particularly in outpatient care.

Who benefits when major health data are released?

1. Governments: Positive indicators are used to showcase policy achievements and programme success.
2. Media: Survey findings generate extensive coverage of emerging health trends.
3. Academia: Researchers use datasets to analyse disease patterns and policy outcomes.
4. Private Sector: Businesses identify opportunities in diagnostics, medicines, wellness services and healthcare delivery.
5. Public Health Community: Survey findings help identify emerging health priorities and vulnerable populations.

Where does India’s health data ecosystem actually fail?

1. Data Availability vs Policy Utilisation: India regularly generates large-scale health datasets. The failure lies in converting findings into policy action.
2. Selective Interpretation: Governments highlight positive indicators and downplay adverse findings. Surveys become tools of narrative management.
3. Delayed Policy Response: Weak indicators are acknowledged but rarely trigger immediate programme redesign.
4. Repetition of Known Problems: Surveys repeatedly document obesity, diabetes, hypertension and nutrition challenges. Structural responses remain limited.
5. Ritualistic Data Discourse: Academic analysis, media coverage and political debate often stop at description rather than institutional reform.

Why does the growing volume of health data not automatically improve health outcomes?

1. Data Do Not Implement Policies: Surveys identify problems. Administrative systems must translate findings into interventions.
2. Weak Accountability Chains: Findings are rarely linked to specific ministries, schemes or officials responsible for corrective action.
3. Budget Disconnect: Survey outcomes often fail to influence expenditure priorities.
4. Fragmented Governance: Health, nutrition, urban planning, food regulation and pharmaceutical policies operate in silos.
5. Absence of Follow-up Mechanisms: Publication of findings is not followed by mandatory review and action processes.

Why has health data increasingly become useful for markets but less useful for public policy?

1. Commercial Signalling: Rising obesity creates demand for weight-loss products, diagnostics and fitness services.
2. Disease Monetisation: Growth in NCDs expands markets for screening, medicines and private healthcare.
3. Private Sector Responsiveness: Businesses rapidly respond to emerging health trends.
4. Public Sector Inertia: Government systems respond more slowly to evidence.
5. Information Asymmetry: Survey findings are often converted into business opportunities before they become policy interventions.

Why does the current survey ecosystem struggle to shape timely decision-making?

1. Time Lag in Data Release: NFHS-6 data were collected during 2023-24 but entered public debate much later.
2. Political Incentives: Governments can attribute negative findings to past conditions and claim credit for positive trends.
3. Delayed Academic Scrutiny: Raw data become available late, slowing independent research.
4. Obsolescence Risk: Policy debates often begin years after data collection.
5. Lost Reform Windows: Administrative opportunities pass before evidence is fully analysed.

Can more health data solve India’s health governance problem?

1. Data Deficit is Not the Core Problem: India already possesses extensive survey infrastructure.
2. Action Deficit is the Core Problem: Institutions lack mechanisms that convert evidence into decisions.
3. Information Without Accountability: Findings remain descriptive when no authority is responsible for correction.
4. Information Without Budgetary Consequences: Data without budgetary consequence are merely information. Survey results have limited impact when resource allocation remains unchanged.
5. Information Without Timeliness: Delayed interpretation reduces policy relevance.

What institutional changes are required to convert health data into policy action?

1. Action Notes After Surveys: National and state governments should publish time-bound response plans within 30-45 days of major survey releases.
2. Clear Accountability Mapping: Each adverse indicator should be linked to a responsible programme and implementing authority.
3. State-Level Health Data Reviews: Survey findings should be examined jointly by health, finance, district administration, experts and civil society.
4. Integrated Health Information Systems: HMIS and Integrated Health Information Platform (IHIP) data should be combined with survey data for policy analytics.
5. Open Access to Raw Data: Researchers and public institutions should receive early access to datasets.
6. Budget-Linked Decision Making: NCD trends, medicine expenditure and nutrition indicators should directly influence resource allocation.
7. Indicator-Specific Responses: Rising anaemia should trigger nutrition interventions, poor hypertension detection should trigger primary healthcare reforms, and high medicine expenditure should trigger drug procurement reforms.

Conclusion

India’s health challenge is no longer the production of data but the institutional failure to act on it. Health surveys must trigger accountability, programme correction and budgetary reprioritisation. More datasets alone will not improve health outcomes; faster interpretation, clearer responsibility and enforceable policy responses remain the missing link.

Mentor’s Comment

India’s fight against tuberculosis (TB) has received a major boost with the publication of the ICMR-led PreVenTB Trial. The trial found that the indigenous vaccine candidates VPM1002 and Immuvac provide protection against both pulmonary TB and the difficult-to-diagnose extrapulmonary TB (EPTB). The findings are significant as they offer new evidence from a large real-world Indian population at a time when India continues to bear one of the world’s highest TB burdens. They also strengthen hopes for achieving TB elimination, even as TB remains the leading infectious disease killer globally. 

Why has a “one-size-fits-all” vaccine approach failed in TB control?

1. Diverse Disease Pathways: TB infection can remain latent for years, progress to subclinical disease, or develop into active pulmonary or extrapulmonary TB.
2. Biological Complexity: Individuals differ in infection status, age, comorbidities, and immune responses.
3. Vaccine Limitations: Previous TB vaccine development largely focused on preventing pulmonary TB.
4. Unrealistic Expectations: Search for a single vaccine capable of preventing all forms of TB has repeatedly disappointed global TB control efforts.

How severe is the TB burden and why does it demand urgent action?

1. Global Mortality: TB continues to kill more people annually than any other infectious disease.
2. Burden in LMICs: Incidence in many low- and middle-income countries remains between 200-300 cases per 100,000 population.
3. Elimination Threshold: TB incidence must decline to 10-20 cases per 100,000 population to approach elimination.
4. Indian Context: India carries one of the world’s highest TB burdens, requiring sustained public health investments.
5. Long-Term Challenge: Elimination demands decades of coordinated interventions rather than a single technological solution.

What are the key pillars of a layered TB elimination strategy?

1. Better Detection
   1. Advanced Diagnostics: Enables identification of subclinical TB before progression to active disease.
   2. Risk-Based Screening: Supports early detection among vulnerable populations.
   3. Public Health Impact: Reduces transmission and disease progression.
2. Preventive Therapy
   1. Latent TB Treatment: Prevents inactive infection from progressing to active disease.
   2. Targeted Intervention: Particularly relevant for household contacts and high-risk populations.
3. Vaccination
   1. Critical Tool: Complements diagnostics and preventive therapy.
   2. Population Protection: Reduces progression from infection to disease.
   3. Integrated Strategy: Most effective when combined with nutrition and case management.

What are the major findings of the PreVenTB Trial?

1. Institution: Conducted by the Indian Council of Medical Research (ICMR).
2. Scale: Conducted at multiple sites across India.
3. Participants: More than 12,700 household contacts of TB patients.
4. Target Group: Individuals aged six years and above, including those with comorbidities and varying infection status.
5. Vaccines Evaluated: VPM1002 and Immuvac.
   1. Efficacy of VPM1002
      1. Extrapulmonary TB Protection: 50.4% efficacy against EPTB.
      2. Pulmonary TB Protection: 21.4% efficacy against pulmonary TB overall.
   2. Efficacy of Immuvac
      1. Overall Protection: 64.6% efficacy against all forms of TB.
      2. Children Protection: More than 60% efficacy among children aged 6–10 years.
      3. Progression Prevention: More than 60% efficacy against progression to disease among individuals with latent infection.

Significance

1. First-of-Its-Kind Evidence: Demonstrates efficacy against both pulmonary and extrapulmonary TB.
2. Real-World Conditions: Large Phase III trial conducted in an Indian population.
3. Broad Coverage: Includes multiple age groups and disease forms.

Why is extrapulmonary TB an important policy concern?

Extrapulmonary tuberculosis (TB) is an active Mycobacterium tuberculosis infection occurring in organs other than the lungs. It accounts for 15% to 40% of all TB cases and primarily affects lymph nodes, pleura, the spine, and the central nervous system.

1. Hidden Burden: Harder to diagnose than pulmonary TB.
2. Missed Cases: Frequently underreported and undetected.
3. Higher Morbidity: Associated with severe complications and mortality.
4. Clinical Impact: A reduction of over 50% in EPTB cases would significantly lower patient suffering and healthcare costs.
5. Novel Evidence: Current findings provide rare vaccine efficacy data against EPTB.

What opportunities do the findings create for children and adolescents?

1. Strong Signal: Vaccine efficacy exceeded 60% among school-age children and adolescents.
2. Policy Gap: India currently lacks a structured TB vaccination strategy beyond infancy.
3. Booster Potential: Findings may support future booster-dose vaccination programmes.
4. Disease Prevention: Offers protection before transition to adulthood, when disease burden increases.

Why is nutrition emerging as a critical component of TB control?

1. Low BMI Impact: Reduced vaccine efficacy observed among individuals with low Body Mass Index.
2. Immune Function: Nutritional status influences vaccine effectiveness and disease resistance.
3. Integrated Approach: Vaccination must be aligned with nutritional interventions.
4. Policy Relevance: Supports strengthening nutrition-TB convergence programmes.

What operational advantages does VPM1002 offer?

1. Single-Dose Vaccine: Simplifies deployment.
2. Modified BCG Platform: Uses an established vaccine platform.
3. Manufacturing Ease: Can be produced at scale.
4. Cost Effectiveness: Suitable for large population programmes.
5. LMIC Relevance: Practical for resource-constrained settings.

What lessons can India draw from previous vaccine decisions?

1. TrueNat Example: Indigenous molecular test adopted by the National TB Elimination Programme before WHO qualification.
2. COVID-19 Response: Covaxin received approval under a “clinical trial mode” during the pandemic to accelerate access while evidence accumulated.
3. Rotavirus Vaccine: Indigenous vaccines were introduced despite early uncertainty and later demonstrated significant reductions in severe disease and child mortality.
4. Policy Lesson: Timely deployment based on credible evidence can yield substantial public health gains.

What should India’s future TB strategy look like?

1. Targeted Vaccination: Deployment of VPM1002 and Immuvac among household contacts and high-risk groups.
2. School-Based Vaccination: Focus on adolescents and school-going children.
3. Preventive Therapy: Integration with latent TB treatment programmes.
4. Nutritional Support: Strengthening nutrition interventions for vulnerable populations.
5. Case-Based Management: Improved diagnosis and treatment adherence.
6. Public Health Investment: Sustained funding and surveillance systems.
7. Combination Approach: Multiple interventions rather than reliance on a single vaccine breakthrough.

Conclusion

The PreVenTB Trial offers a promising pathway for strengthening India’s TB elimination efforts through indigenous vaccines and targeted interventions. Achieving the goal of a TB-Mukt Bharat by 2025 and contributing to SDG 3’s target of ending the TB epidemic by 2030 will require a combination of vaccination, nutrition, early detection, and sustained public health action.

Value Addition

Tuberculosis (TB): Key Facts

1. Causative Agent: Mycobacterium tuberculosis
2. Transmission: Airborne droplets
3. Types: Pulmonary TB and Extrapulmonary TB
4. Latent TB: Infection without symptoms; can later progress to active disease
5. SDG Target: End TB epidemic by 2030

National TB Elimination Programme (NTEP)

1. Formerly Revised National TB Control Programme (RNTCP)
2. Based on National Strategic Plan for TB Elimination
3. Uses molecular diagnostics and universal drug susceptibility testing
4. Provides free diagnosis and treatment

Major Government Initiatives

1. Ni-kshay Portal: Facilitates digital tracking of TB patients.
2. Ni-kshay Poshan Yojana: Provides nutritional support to TB patients.
3. TB Mukt Bharat Abhiyan: Supports community participation in TB elimination.
4. PM TB Mukt Bharat Abhiyan: Encourages adoption of TB patients through Ni-kshay Mitras.